Tailoring clinical trials to economic analysis
ERT for breast cancer survivors?
Healthcare in the future
Leuprorelin works - but at what cost?
News in brief …
Arguing the economics of dying
Relating medical insurance to healthcare access
News in brief …
Rational approach to hypertension needed
How do drug firms tackle healthcare changes?
News in brief …
Dramatic savings with combined therapy for severe lupus nephritis
Cost savings with carboplatin
Factors to consider in cost-effectiveness analyses of thrombolytics
Antidepressant prescribing for elderly needs improving
IP vs SC insulin in intensive diabetes management
Developing models for implementing formulary policies
Word-of-mouth works best
Cefalosporins most expensive option
Costing asthma …
Cost considerations …
Substantial savings with piroxicam
PBSC transplantation in myeloma
Lack of support costly in stroke
Quality of Life Aspects
M. avium treatment improves QOL
Atenolol and metoprolol ‘equivalent’?
News in brief …
Costing time in the demand for healthcare
Your Questions Answered
Costs fall as prescribing rises
Looking at Japan's healthcare spending
NZ's expanding antidepressant bill targeted
Glaxo eyes up Lilly's PBM